Indian J Microbiol. 2025 Mar;65(1):424-438. doi: 10.1007/s12088-024-01266-x. Epub 2024 Apr 6.
ABSTRACT
Therapeutic options for preventing the trajectory of multi-drug resistance bacterial pathogens could rely on the effort to design a novel technique to develop a potent antimicrobial agent to counter the key issue. To curb the current outbreak, we synthesized first generation of antimicrobial amine-modified carbon quantum dots, CQDs-NH2 as carbon precursors followed by hydrothermal carbonization of ethylenediamine/citric acid, and postmodified with propargyl alcohol (CQDs-1) and quinoline derivative; 8-hydroxy quinoline (CQDs-2) through Cu(I)-catalyzed azide-alkyne cycloaddition. The novel clicked 1,2,3-triazole functionalized CQDs-NH2 templates, were evaluated against standard Gram-positive; Staphylococcus aureus (S. aureus), and Gram-negative; Escherichia coli (E. coli), MRSA, along with clinical-resistant diabetic foot PUS swab isolated bacterial pathogens by 96-well method as well as agar-well diffusion method, to unleased the potential antibacterial activity. 1,2,3-triazole functionalized CQDs-NH2 template showed enhanced antibacterial activity against distinct bacterial strains, with minimum inhibitory concentration for standard bacteria, MRSA-bacteria, and clinical resistant bacterial pathogens in the range of 0.25-8, 64-128, and 128-256 μg mL-1 respectively. This nanobiotic template displays good potential through the hybridization of 1,2,3-triazole with antibacterial pharmacophores CQDs-NH2 and quinoline, to overcome drug resistance, reduce toxicity, and improve pharmacokinetic profiles. The findings of this study might have a favorable impact on antibiotic pharmacodynamics and, as a result, nanobiotic dosing regimens as well as clinical outcomes.
SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12088-024-01266-x.
PMID:40371036 | PMC:PMC12069200 | DOI:10.1007/s12088-024-01266-x